Citation 71115

LIKHITWITAYAWUID,K: ANGERHOFER,CK: CHAI,HB: PEZZUTO,JM: CORDELL,GA: RUANGRUNGSI,N:. (1993). CYTOTOXIC AND ANTIMALARIAL ALKALOIDS FROM THE TUBERS OF STEPHANIA PIERREI.. 56(9)

Citation Details

TitleCYTOTOXIC AND ANTIMALARIAL ALKALOIDS FROM THE TUBERS OF STEPHANIA PIERREI.
AuthorsLIKHITWITAYAWUID,K: ANGERHOFER,CK: CHAI,HB: PEZZUTO,JM: CORDELL,GA: RUANGRUNGSI,N:
Year1993
Volume56
Issue9

Summary

Year: 1993

Journal: Unknown

Organisms and Their Experiments (1)

Stephania pierrei (MENISPERMACEAE)

Experiment #Pharmacology TypeWorktypesCompoundResults
1Not specified
VOUCHER SPECIMEN REPORTED FOR
NoneNone
2
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
None
ACTIVE
3
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
None
ACTIVE
4
ANTIMALARIAL ACTIVITY
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
None
ACTIVE
5
ANTIMALARIAL ACTIVITY
PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
None
ACTIVE
6Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
PALMATINE,TETRAHYDRO: (-):
None
7
ANTIMALARIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
PALMATINE,TETRAHYDRO: (-):
INACTIVE
8
ANTIMALARIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
PALMATINE,TETRAHYDRO: (-):
ACTIVE
9Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
XYLOPININE,(-):
None
10
ANTIMALARIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
XYLOPININE,(-):
INACTIVE
11
ANTIMALARIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
XYLOPININE,(-):
INACTIVE
12Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
DELAVAINE,(-):#
None
13
ANTIMALARIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
DELAVAINE,(-):#
INACTIVE
14
ANTIMALARIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
DELAVAINE,(-):#
INACTIVE
15Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
CAPAURINE,(-):
None
16
ANTIMALARIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
CAPAURINE,(-):
ACTIVE
17
ANTIMALARIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
CAPAURINE,(-):
ACTIVE
18Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
THAICANINE,(-):
None
19
ANTIMALARIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
THAICANINE,(-):
ACTIVE
20
ANTIMALARIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
THAICANINE,(-):
ACTIVE
21Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
STEPHABINE,TETRAHYDRO: (-):
None
22
ANTIMALARIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
STEPHABINE,TETRAHYDRO: (-):
ACTIVE
23
ANTIMALARIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
STEPHABINE,TETRAHYDRO: (-):
ACTIVE
24Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
CORYDALMINE,(-):
None
25
ANTIMALARIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
CORYDALMINE,(-):
ACTIVE
26
ANTIMALARIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
CORYDALMINE,(-):
ACTIVE
27Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
DICENTRINE,(-):
None
28
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
DICENTRINE,(-):
ACTIVE
29
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
DICENTRINE,(-):
ACTIVE
30
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
DICENTRINE,(-):
ACTIVE
31
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
DICENTRINE,(-):
ACTIVE
32
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
DICENTRINE,(-):
ACTIVE
33
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
DICENTRINE,(-):
ACTIVE
34
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
DICENTRINE,(-):
ACTIVE
35
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
DICENTRINE,(-):
ACTIVE
36
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
DICENTRINE,(-):
ACTIVE
37
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
DICENTRINE,(-):
ACTIVE
38
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
DICENTRINE,(-):
ACTIVE
39
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
DICENTRINE,(-):
WEAK ACTIVITY
40
ANTIMALARIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
DICENTRINE,(-):
ACTIVE
41
ANTIMALARIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
DICENTRINE,(-):
ACTIVE
42Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
LAURELINE,ISO: (-):
None
43
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
LAURELINE,ISO: (-):
ACTIVE
44
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
LAURELINE,ISO: (-):
ACTIVE
45
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
LAURELINE,ISO: (-):
ACTIVE
46
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
LAURELINE,ISO: (-):
ACTIVE
47
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
LAURELINE,ISO: (-):
INACTIVE
48
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
LAURELINE,ISO: (-):
ACTIVE
49
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
LAURELINE,ISO: (-):
INACTIVE
50
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
LAURELINE,ISO: (-):
ACTIVE
51
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
LAURELINE,ISO: (-):
ACTIVE
52
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
LAURELINE,ISO: (-):
ACTIVE
53
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
LAURELINE,ISO: (-):
ACTIVE
54
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
LAURELINE,ISO: (-):
WEAK ACTIVITY
55
ANTIMALARIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
LAURELINE,ISO: (-):
ACTIVE
56
ANTIMALARIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
LAURELINE,ISO: (-):
ACTIVE
57Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
PHANOSTENINE,(-):
None
58
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
PHANOSTENINE,(-):
ACTIVE
59
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
PHANOSTENINE,(-):
ACTIVE
60
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
PHANOSTENINE,(-):
ACTIVE
61
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
PHANOSTENINE,(-):
ACTIVE
62
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
PHANOSTENINE,(-):
ACTIVE
63
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
PHANOSTENINE,(-):
WEAK ACTIVITY
64
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
PHANOSTENINE,(-):
WEAK ACTIVITY
65
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
PHANOSTENINE,(-):
ACTIVE
66
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
PHANOSTENINE,(-):
ACTIVE
67
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
PHANOSTENINE,(-):
ACTIVE
68
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
PHANOSTENINE,(-):
ACTIVE
69
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
PHANOSTENINE,(-):
ACTIVE
70
ANTIMALARIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
PHANOSTENINE,(-):
ACTIVE
71
ANTIMALARIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
PHANOSTENINE,(-):
ACTIVE
72Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
XYLOPINE
None
73
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
XYLOPINE
ACTIVE
74
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
XYLOPINE
ACTIVE
75
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
XYLOPINE
ACTIVE
76
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
XYLOPINE
ACTIVE
77
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
XYLOPINE
ACTIVE
78
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
XYLOPINE
ACTIVE
79
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
XYLOPINE
WEAK ACTIVITY
80
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
XYLOPINE
ACTIVE
81
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
XYLOPINE
ACTIVE
82
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
XYLOPINE
ACTIVE
83
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
XYLOPINE
ACTIVE
84
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
XYLOPINE
ACTIVE
85
ANTIMALARIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
XYLOPINE
ACTIVE
86
ANTIMALARIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
XYLOPINE
ACTIVE
87Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
ANONAINE,(-):
None
88
ANTIMALARIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANONAINE,(-):
ACTIVE
89
ANTIMALARIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANONAINE,(-):
ACTIVE
90
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ANONAINE,(-):
INACTIVE
91
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ANONAINE,(-):
INACTIVE
92
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ANONAINE,(-):
INACTIVE
93
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ANONAINE,(-):
INACTIVE
94
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ANONAINE,(-):
INACTIVE
95
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ANONAINE,(-):
INACTIVE
96
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ANONAINE,(-):
INACTIVE
97
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ANONAINE,(-):
INACTIVE
98
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ANONAINE,(-):
INACTIVE
99
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ANONAINE,(-):
INACTIVE
100
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ANONAINE,(-):
INACTIVE
101
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ANONAINE,(-):
INACTIVE
102Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
CASSYTHICINE,(-):
None
103
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
CASSYTHICINE,(-):
WEAK ACTIVITY
104
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
CASSYTHICINE,(-):
WEAK ACTIVITY
105
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
CASSYTHICINE,(-):
ACTIVE
106
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
CASSYTHICINE,(-):
ACTIVE
107
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
CASSYTHICINE,(-):
INACTIVE
108
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
CASSYTHICINE,(-):
WEAK ACTIVITY
109
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
CASSYTHICINE,(-):
WEAK ACTIVITY
110
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
CASSYTHICINE,(-):
WEAK ACTIVITY
111
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
CASSYTHICINE,(-):
ACTIVE
112
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
CASSYTHICINE,(-):
WEAK ACTIVITY
113
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
CASSYTHICINE,(-):
WEAK ACTIVITY
114
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
CASSYTHICINE,(-):
WEAK ACTIVITY
115
ANTIMALARIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
CASSYTHICINE,(-):
ACTIVE
116
ANTIMALARIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
CASSYTHICINE,(-):
ACTIVE
117Not specified
UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
DICENTRINE,NOR: (-):
None
118
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
DICENTRINE,NOR: (-):
ACTIVE
119
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
DICENTRINE,NOR: (-):
ACTIVE
120
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
DICENTRINE,NOR: (-):
ACTIVE
121
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
DICENTRINE,NOR: (-):
ACTIVE
122
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
DICENTRINE,NOR: (-):
ACTIVE
123
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
DICENTRINE,NOR: (-):
ACTIVE
124
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
DICENTRINE,NOR: (-):
ACTIVE
125
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
DICENTRINE,NOR: (-):
ACTIVE
126
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
DICENTRINE,NOR: (-):
ACTIVE
127
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
DICENTRINE,NOR: (-):
ACTIVE
128
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
DICENTRINE,NOR: (-):
ACTIVE
129
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
DICENTRINE,NOR: (-):
WEAK ACTIVITY
130
ANTIMALARIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
DICENTRINE,NOR: (-):
ACTIVE
131
ANTIMALARIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
DICENTRINE,NOR: (-):
ACTIVE
132Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
SINOACUTINE
None
133
ANTIMALARIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
SINOACUTINE
EQUIVOCAL
134
ANTIMALARIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
SINOACUTINE
EQUIVOCAL
135Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
CODAMINE,(+):
None
136
ANTIMALARIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
CODAMINE,(+):
ACTIVE
137
ANTIMALARIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
CODAMINE,(+):
ACTIVE
138Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
RETICULINE,(+):
None
139
ANTIMALARIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
RETICULINE,(+):
ACTIVE
140
ANTIMALARIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
RETICULINE,(+):
ACTIVE
141Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
ASIMILOBINE,(-):
None
142
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ASIMILOBINE,(-):
ACTIVE
143
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ASIMILOBINE,(-):
ACTIVE
144
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ASIMILOBINE,(-):
ACTIVE
145
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ASIMILOBINE,(-):
ACTIVE
146
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ASIMILOBINE,(-):
INACTIVE
147
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ASIMILOBINE,(-):
ACTIVE
148
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ASIMILOBINE,(-):
WEAK ACTIVITY
149
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ASIMILOBINE,(-):
ACTIVE
150
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ASIMILOBINE,(-):
ACTIVE
151
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ASIMILOBINE,(-):
ACTIVE
152
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ASIMILOBINE,(-):
ACTIVE
153
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ASIMILOBINE,(-):
ACTIVE
154
ANTIMALARIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ASIMILOBINE,(-):
ACTIVE
155
ANTIMALARIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ASIMILOBINE,(-):
ACTIVE
156Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
ROEMEROLINE,(-):
None
157
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ROEMEROLINE,(-):
WEAK ACTIVITY
158
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ROEMEROLINE,(-):
WEAK ACTIVITY
159
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ROEMEROLINE,(-):
ACTIVE
160
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ROEMEROLINE,(-):
ACTIVE
161
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ROEMEROLINE,(-):
INACTIVE
162
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ROEMEROLINE,(-):
WEAK ACTIVITY
163
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ROEMEROLINE,(-):
INACTIVE
164
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ROEMEROLINE,(-):
WEAK ACTIVITY
165
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ROEMEROLINE,(-):
ACTIVE
166
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ROEMEROLINE,(-):
WEAK ACTIVITY
167
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ROEMEROLINE,(-):
WEAK ACTIVITY
168
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ROEMEROLINE,(-):
WEAK ACTIVITY
169
ANTIMALARIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ROEMEROLINE,(-):
ACTIVE
170
ANTIMALARIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ROEMEROLINE,(-):
ACTIVE
171Not specified
UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
ASIMILOBINE-2-O-BETA-D-GLUCOSIDE,(-):
None
172
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ASIMILOBINE-2-O-BETA-D-GLUCOSIDE,(-):
INACTIVE
173
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ASIMILOBINE-2-O-BETA-D-GLUCOSIDE,(-):
INACTIVE
174
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ASIMILOBINE-2-O-BETA-D-GLUCOSIDE,(-):
INACTIVE
175
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ASIMILOBINE-2-O-BETA-D-GLUCOSIDE,(-):
INACTIVE
176
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ASIMILOBINE-2-O-BETA-D-GLUCOSIDE,(-):
INACTIVE
177
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ASIMILOBINE-2-O-BETA-D-GLUCOSIDE,(-):
INACTIVE
178
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ASIMILOBINE-2-O-BETA-D-GLUCOSIDE,(-):
INACTIVE
179
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ASIMILOBINE-2-O-BETA-D-GLUCOSIDE,(-):
INACTIVE
180
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ASIMILOBINE-2-O-BETA-D-GLUCOSIDE,(-):
INACTIVE
181
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ASIMILOBINE-2-O-BETA-D-GLUCOSIDE,(-):
INACTIVE
182
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ASIMILOBINE-2-O-BETA-D-GLUCOSIDE,(-):
INACTIVE
183
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ASIMILOBINE-2-O-BETA-D-GLUCOSIDE,(-):
INACTIVE
184
ANTIMALARIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ASIMILOBINE-2-O-BETA-D-GLUCOSIDE,(-):
INACTIVE
185
ANTIMALARIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ASIMILOBINE-2-O-BETA-D-GLUCOSIDE,(-):
INACTIVE
186Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
PALMATINE,TETRAHYDRO: N-METHYL:
None
187
ANTIMALARIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
PALMATINE,TETRAHYDRO: N-METHYL:
INACTIVE
188
ANTIMALARIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
PALMATINE,TETRAHYDRO: N-METHYL:
INACTIVE
189Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
OBLONGINE,(DL):
None
190
ANTIMALARIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
OBLONGINE,(DL):
INACTIVE
191
ANTIMALARIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
OBLONGINE,(DL):
INACTIVE
192Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
MAGNOFLORINE
None
193
ANTIMALARIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
MAGNOFLORINE
INACTIVE
194
ANTIMALARIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
MAGNOFLORINE
INACTIVE
Show SPARQL Queries (1)